Science News
from research organizations

Study provides insights on enzyme that helps direct the immune response to kidney injury

Date:
February 12, 2015
Source:
American Society of Nephrology (ASN)
Summary:
An enzyme called heme oxygenase-1 (HO-1) affects immune cells as they travel through the body in response to kidney injury, research shows. In mice, the absence of HO-1 leads to poor recovery after acute kidney injury.
Share:
FULL STORY

An enzyme known to be important in the body's response to kidney injury exerts its protective effects, in part, by affecting the immune system, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings could lead to new treatments for patients with acute kidney injury (AKI).

AKI is an abrupt decline in kidney function that often arises after major surgeries or severe infections. An enzyme called heme oxygenase-1 (HO-1) is known to be important in the body's protective response to AKI. In their efforts to uncover the specific effects of HO-1 in this response, a team of researchers led by Anupam Agarwal, MD, James F. George, PhD, Travis Hull, BS, and Ahmed Kamal, MD (University of Alabama at Birmingham) found that HO-1 helps to direct a specific subset of immune cells, called myeloid cells, as they traffic to and from the kidney after it is injured.

"This pre-clinical study more completely defines the cellular compartments through which HO-1 exerts its protective effects in AKI, thus paving the way for the development of targeted novel therapeutic strategies aimed at preventing the significant morbidity and mortality caused by AKI in patients," said Dr. Agarwal. "More importantly, our studies discovered that the absence of HO-1 in myeloid cells had a dramatic effect on recovery after AKI, suggesting that HO-1 could be an important target in preventing the transition of AKI to chronic kidney disease."

In an accompanying editorial, Gilbert Kinsey, PharmD, PhD (University of Virginia) noted that the findings significantly advance researchers' understanding of the role of HO-1 following kidney injury. "Given the human relevance of HO-1 in AKI and the growing understanding of the myeloid cells in renal health and disease, these studies by Hull et al. provide the foundation for a whole new area of AKI research," he wrote.


Story Source:

Materials provided by American Society of Nephrology (ASN). Note: Content may be edited for style and length.


Journal Reference:

  1. T. D. Hull, A. I. Kamal, R. Boddu, S. Bolisetty, L. Guo, C. C. Tisher, S. Rangarajan, B. Chen, L. M. Curtis, J. F. George, A. Agarwal. Heme Oxygenase-1 Regulates Myeloid Cell Trafficking in AKI. Journal of the American Society of Nephrology, 2015; DOI: 10.1681/ASN.2014080770

Cite This Page:

American Society of Nephrology (ASN). "Study provides insights on enzyme that helps direct the immune response to kidney injury." ScienceDaily. ScienceDaily, 12 February 2015. <www.sciencedaily.com/releases/2015/02/150212183255.htm>.
American Society of Nephrology (ASN). (2015, February 12). Study provides insights on enzyme that helps direct the immune response to kidney injury. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/02/150212183255.htm
American Society of Nephrology (ASN). "Study provides insights on enzyme that helps direct the immune response to kidney injury." ScienceDaily. www.sciencedaily.com/releases/2015/02/150212183255.htm (accessed May 23, 2017).

RELATED STORIES